Literature DB >> 22820807

Frequency and predictors for late start of antiretroviral therapy in primary care clinics, Kampala, Uganda.

Ibrahim Sendagire1, Frank Cobelens, Andrew Kambugu, Joseph Konde-Lule, Maarten Schim van der Loeff.   

Abstract

BACKGROUND: Access to antiretroviral treatment (ART) has improved greatly in many parts of the world, including Uganda, yet, many patients delay to start ART even when registered within the HIV services. We assessed, in a routine ambulatory care setting, what proportion of patients start ART late and the associated factors.
METHODS: We conducted a cross-sectional study from a cohort of adult, HIV-infected, ART-naive patients seeking care at 3 primary care centers in Kampala, Uganda. ART eligibility at the time was World Health Organization clinical stage 4 or CD4 <200 cells/μL. We defined late start of ART as starting ART at CD4 count <100 cells/μL and analyzed associated factors using multivariable logistic regression.
RESULTS: Between May 2008 and August 2009, 326 adults were studied. Two hundred eighteen (67%) were women; the median age was 34 years (range, 18-71). The median CD4 count was 132 cells/μL (range, 1-505). Thirty-one patients (10%) were in World Health Organization stage 4. One hundred twenty-three patients (37.7%) were initiated on ART with CD4 cells <100 cells/μL. Being male [adjusted OR (aOR): 2.4; 95% confidence interval: 1.3 to 4.2, P = 0.002] and having no employment (aOR: 1.9; 95% confidence interval: 1.2 to 3.3, P = 0.012) were associated with late start of ART. Being older, being married, and showing signs of alcohol dependence were associated with an earlier start of ART.
CONCLUSIONS: A considerable proportion of patients started ART at very low CD4 counts. Male and unemployed patients were more likely and married people and those aged 40 years or older were less likely to start ART late.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22820807     DOI: 10.1097/QAI.0b013e318265aad7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  4 in total

1.  ImPROving TB outcomes by modifying LIFE-style behaviours through a brief motivational intervention followed by short text messages (ProLife): study protocol for a randomised controlled trial.

Authors:  Andrew Stephen Moriarty; Goedele Maria Louwagie; Noreen Dadirai Mdege; Neo Morojele; John Tumbo; Olufemi Babatunde Omole; Max Oscar Bachmann; Mona Kanaan; Astrid Turner; Steve Parrott; Kamran Siddiqi; Olalekan Abdulwahab Ayo-Yusuf
Journal:  Trials       Date:  2019-07-26       Impact factor: 2.279

2.  Late ART Initiation among adult HIV patients at university of Gondar Hospital, NorthWest Ethiopia.

Authors:  Degefaye Zelalem Anlay; Bewket Tadesse Tiruneh; Berihun Assefa Dachew
Journal:  Afr Health Sci       Date:  2019-09       Impact factor: 0.927

3.  Factors Associated With Late Antiretroviral Therapy Initiation Among People Living With HIV in Southern Iran: A Historical Cohort Study.

Authors:  Sima Afrashteh; Mohammad Fararouei; Haleh Ghaem; Zahra Gheibi
Journal:  Front Public Health       Date:  2022-06-17

4.  Factors associated with access to HIV care services in eastern Uganda: the Kumi home based HIV counseling and testing program experience.

Authors:  David Lubogo; John Bosco Ddamulira; Raymond Tweheyo; Henry Wamani
Journal:  BMC Fam Pract       Date:  2015-11-03       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.